RNTX stock

Rein Therapeutics Inc (RNTX) financials · $80.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Rein Therapeutics Inc (RNTX) $80.6M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/AN/A
Operating Income-$50.6M-$65.1M
Net Income-$49.9M-$62.9M
EPS (Diluted)-$1.96-$3.51
Cached annual balance sheet
LineFY2025FY2024
Total Assets$24.2M$62.2M
Current Assets$4.33M$13.7M
Cash & Equivalents$3.21M$12.9M
PP&EN/A$1.00K
Total Liabilities$7.24M$7.80M
Current Liabilities$6.18M$5.75M
Shareholders' Equity$16.9M$54.4M
Retained Earnings-$401.3M-$351.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$19.4M-$22.3M
Investing Cash FlowN/AN/A
Financing Cash Flow$9.76M$17.8M
Net Change in Cash-$9.65M-$4.47M
These statements as JSON? API free 100/day

FAQ

What is RNTX P/E and revenue?

Rein Therapeutics Inc (RNTX) $80.6M cap.

What is RNTX revenue?

RNTX income-statement cache has no revenue figure yet.

Is RNTX profitable?

Rein Therapeutics Inc last cached net income is -$49.9M (FY2025).

What are RNTX total assets?

Rein Therapeutics Inc last cached total assets are $24.2M (FY2025).

What is RNTX free cash flow?

No cached cash-flow row for RNTX yet.

Not investment advice. Cached statements, not a live tape.